SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation
出版年份 2016 全文链接
标题
SIRT2 activates G6PD to enhance NADPH production and promote leukaemia cell proliferation
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-09-02
DOI
10.1038/srep32734
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A SIRT2-Selective Inhibitor Promotes c-Myc Oncoprotein Degradation and Exhibits Broad Anticancer Activity
- (2016) Hui Jing et al. CANCER CELL
- Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia
- (2016) Xue Gao et al. Nature Communications
- Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia
- (2015) B. J. Wouters et al. BLOOD
- Cancer Metabolism: Targeting metabolic pathways in cancer therapy
- (2015) Shree Ram Singh et al. CANCER LETTERS
- Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids
- (2015) A. D. Southam et al. CANCER RESEARCH
- AMPK Protects Leukemia-Initiating Cells in Myeloid Leukemias from Metabolic Stress in the Bone Marrow
- (2015) Yusuke Saito et al. Cell Stem Cell
- TRAF6-Mediated SM22α K21 Ubiquitination Promotes G6PD Activation and NADPH Production, Contributing to GSH Homeostasis and VSMC Survival In Vitro and In VivoNovelty and Significance
- (2015) Li-Hua Dong et al. CIRCULATION RESEARCH
- Acute Activation of Oxidative Pentose Phosphate Pathway as First-Line Response to Oxidative Stress in Human Skin Cells
- (2015) Andreas Kuehne et al. MOLECULAR CELL
- WT1 Recruits TET2 to Regulate Its Target Gene Expression and Suppress Leukemia Cell Proliferation
- (2015) Yiping Wang et al. MOLECULAR CELL
- Targeting aberrant cancer metabolism – The role of sirtuins
- (2015) Robert Kleszcz et al. Pharmacological Reports
- Emerging Role of Sirtuin 2 in the Regulation of Mammalian Metabolism
- (2015) Pedro Gomes et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Inhibition of pentose phosphate pathway suppresses acute myelogenous leukemia
- (2015) Yan Chen et al. TUMOR BIOLOGY
- Selective Sirt2 inhibition by ligand-induced rearrangement of the active site
- (2015) Tobias Rumpf et al. Nature Communications
- Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer
- (2015) Hong-Bin Yang et al. Nature Communications
- O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
- (2015) Xiongjian Rao et al. Nature Communications
- Regulation of G6PD acetylation by KAT9/SIRT2 modulates NADPH homeostasis and cell survival during oxidative stress
- (2014) Y.-P. Wang et al. EMBO JOURNAL
- Human telomerase specialization for repeat synthesis by unique handling of primer-template duplex
- (2014) R. A. Wu et al. EMBO JOURNAL
- Lysine Acetylation Activates 6-Phosphogluconate Dehydrogenase to Promote Tumor Growth
- (2014) Changliang Shan et al. MOLECULAR CELL
- The pentose phosphate pathway and cancer
- (2014) Krushna C. Patra et al. TRENDS IN BIOCHEMICAL SCIENCES
- Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
- (2014) Takehiro Yamamoto et al. Nature Communications
- Regulation of the pentose phosphate pathway in cancer
- (2014) Peng Jiang et al. Protein & Cell
- PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis
- (2013) Xuehui Hong et al. GUT
- TAp73 enhances the pentose phosphate pathway and supports cell proliferation
- (2013) Wenjing Du et al. NATURE CELL BIOLOGY
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease
- (2012) Peter A. Hecker et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients
- (2012) Elias Bou Samra et al. BRITISH JOURNAL OF HAEMATOLOGY
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- The pentose phosphate pathway: An antioxidant defense and a crossroad in tumor cell fate
- (2012) Chiara Riganti et al. FREE RADICAL BIOLOGY AND MEDICINE
- Modulation of doxorubicin resistance by the glucose-6-phosphate dehydrogenase activity
- (2011) Manuela Polimeni et al. BIOCHEMICAL JOURNAL
- Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCPligases in response to DNA damage
- (2011) Xin Zhou et al. BIOCHEMICAL JOURNAL
- Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis
- (2011) O Meynet et al. LEUKEMIA
- Targeting glycolysis in leukemia: A novel inhibitor 3-BrOP in combination with rapamycin
- (2011) Lauren J. Akers et al. LEUKEMIA RESEARCH
- Acetylation Targets the M2 Isoform of Pyruvate Kinase for Degradation through Chaperone-Mediated Autophagy and Promotes Tumor Growth
- (2011) Lei Lv et al. MOLECULAR CELL
- p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase
- (2011) Peng Jiang et al. NATURE CELL BIOLOGY
- Metabolic genes in cancer: Their roles in tumor progression and clinical implications
- (2010) Eiji Furuta et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair
- (2010) Claudia Cosentino et al. EMBO JOURNAL
- The Proapoptotic Function of Noxa in Human Leukemia Cells Is Regulated by the Kinase Cdk5 and by Glucose
- (2010) Xazmin H. Lowman et al. MOLECULAR CELL
- Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
- (2008) E. Hulleman et al. BLOOD
- Glucose-6-phosphate dehydrogenase deficiency
- (2008) MD Cappellini et al. LANCET
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started